EUVIMEDSkopri EUVIMED
Open access

Linking lipids, Alzheimer's and LXRs?

Nilay V Patel, Barry Marc Forman

Nuclear Receptor Signaling · 2004

DOI: 10.1621/nrs.02001 ↗

At a glance

Journal article in Nuclear Receptor Signaling, 2004. Written by Nilay V Patel and 1 co-authors. Institution: Gonda Diabetes Center, City of Hope National Medical Center, Duarte, CA 91010, USA. Cited 6 times so far (Crossref); 44 references. The full text is freely available in PubMed Central.

AstrattDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Deposition of the β-amyloid (Aβ) peptide is thought to underlie development of Alzheimer's disease (AD). This pathological linkage has spurred considerable interest in therapeutic strategies to reduce Aβ production. It is becoming increasingly clear that altered cholesterol homeostasis can modulate Aβ production and/or accumulation. In this review, we discuss the molecular pathology of AD, the cholesterol connection and recent data suggesting that the oxysterol receptor, liver X receptor LXR (NR1H2 and NR1H3), may modulate these events.

Authors and institutions

  • Gonda Diabetes Center, City of Hope National Medical Center, Duarte, CA 91010, USA.

Cite

APA

Patel, N. V., & Forman, B. M. (2004). Linking lipids, Alzheimer's and LXRs?. Nuclear Receptor Signaling. https://doi.org/10.1621/nrs.02001

Vancouver

Patel NV, Forman BM. Linking lipids, Alzheimer's and LXRs?. Nuclear Receptor Signaling. 2004. doi:10.1621/nrs.02001

BibTeX
@article{Patel2004,
  author = {Patel, Nilay V and Forman, Barry Marc},
  title = {Linking lipids, Alzheimer's and LXRs?},
  journal = {Nuclear Receptor Signaling},
  year = {2004},
  doi = {10.1621/nrs.02001}
}
Start for free →